Loading...
XHKG
1789
Market cap723mUSD
Jul 09, Last price  
5.29HKD
1D
-2.40%
1Q
-25.70%
IPO
98.13%
Name

AK Medical Holdings Ltd

Chart & Performance

D1W1MN
XHKG:1789 chart
P/E
14.47
P/S
3.31
EPS
0.32
Div Yield, %
1.36%
Shrs. gr., 5y
0.23%
Rev. gr., 5y
7.44%
Revenues
1.48b
+10.11%
148,278,000206,164,000270,777,000372,700,000600,562,000926,705,0001,035,386,000761,441,0001,052,047,0001,093,862,0001,346,377,0001,482,439,000
Net income
339m
+23.79%
51,721,00064,907,00077,326,000105,376,000144,936,000266,992,000314,007,00092,619,000204,772,000182,104,000273,926,000339,094,000
CFO
419m
-7.10%
51,092,00036,302,00069,643,000116,652,000127,992,000144,662,000205,257,000176,621,000242,919,00033,935,000451,072,000419,030,878
Dividend
Jun 23, 20260.118 HKD/sh

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

AK Medical Holdings Limited, an investment holding enterprise, specializes in the research, development, production, and worldwide commercialization of orthopedic joint implants and related medical devices under the AK Medical brand. Its comprehensive product offerings encompass conventional knee, hip, and spine replacement implants, as well as advanced 3D-printed solutions like hip implants, artificial vertebral bodies, and spinal interbody cages. The company further expands its operations by distributing orthopedic products from third-party manufacturers and by fabricating surgical instruments and medical irrigators. Its diverse client base spans distributors, hospitals, physicians, surgeons, and directly serves patients. Established in Beijing, People's Republic of China, in 2003, AK Medical Holdings Limited functions as a subsidiary of Ximalaya Limited.
IPO date
Dec 20, 2017
Employees
1,082
Domiciled in
CN
Incorporated in
KY

Valuation

Title
CNY in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2025‑122024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT